PwC's Next in Health
Hosted by Glenn Hunzinger, US Health Industries Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech, and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it is policy, AI, innovation, care delivery, business model reinvention, or bold moves shaping the future. If it is happening in health industries, we are talking about it.
Podcasting since 2020 • 62 episodes
PwC's Next in Health
Latest Episodes
The One Big Beautiful Bill: What It Means for the Future of U.S. Healthcare
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, sits down with Nichole Montgomery, Shannon O’Shea, and Phil Sclafani to unpack the sweeping implications of the newly signed One Big Beautiful Bill Act (OBBBA). With nearly a third of ...
•
15:23
Strategic Dealmaking in Health: Navigating Midyear Trends in 2025
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Nick Donkar, PwC’s U.S. Health Services Deals Leader, and Roel Van den Akker, PwC’s Pharma and Life Sciences Deals Leader, to discuss the 2025 midyear deals outlook acros...
•
Season 5
•
Episode 17
•
19:39
Taking a closer look at the Most Favored Nation Pricing Executive Order
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, and Phil Scalfani, PwC’s Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration’s executive order on Most Favored Nation (MFN) drug pricing and its far-re...
•
Season 5
•
Episode 16
•
16:47
Navigating the FDA disruption: 4 key actions for pharma
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, connects with Matt Rich, PwC’s Pharma and Life Sciences R&D Leader, to unpack the recent disruption at the FDA and what it means for the pharmaceutical and biotech sectors. They di...
•
Season 5
•
Episode 15
•
10:05
Strategic Shifts: Navigating China's Biotech Boom and Its Impact on US Pharma
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader and Roel van den Akker, PwC’s Pharma and Life Sciences Deals Leader discuss the rapid rise of China’s biotech industry and what it means for U.S. pharmaceutical companies. They discuss ...
•
Season 5
•
Episode 14
•
11:46